Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF | V.TLT.W

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Post by GRAMPS1996on May 02, 2017 7:22pm
158 Views
Post# 26195397

bladder cancer

bladder cancer
May 2, 2017 4:42 pm

Women likely to ignore early signs of bladder cancer: doctor

  •  









WATCH: It’s the fifth most common cancer in Canada, but for women, the early signs of bladder cancer are easy to miss. Heather Yourex-West explains.

A A

Zina Lombardi was a healthy, active 40-year-old mother of three when she learned she had bladder cancer.

“In late 2010, I was noticing some streaking, some blood when I would go to the bathroom. I really didn’t have any other symptoms, so like most people, I ignored it for probably two or three months,” Lombardi said.

READ MORE: 5 things you didn’t know about bladder cancer in Canada

 

According to Bladder Cancer Canada, about 9,000 news cases of bladder cancer are diagnosed in Canada each year, and in most cases blood in the urine is the first warning sign.

The trouble is, for women, that symptom is most often linked to another more common health problem, according to urologist Dr. Peter Black.

“It’s often assumed that blood is a urinary tract infection so the necessary tests aren’t done to show that it’s bladder cancer,” Black said.

Lombardi’s stage two bladder cancer diagnosis meant that she required four rounds of chemotherapy and surgery to remove her bladder.

Recovery, she admits, was long and difficult, but today she’s feeling good and sharing her story so that others will learn the signs.

WATCH: Bladder cancer drug will no longer be made by manufacturer

“What I say to people is — if you see blood in your urine, go have it looked at and make sure if you’re told that it is a bladder infection, that it’s confirmed with a urinalysis that it really is an infection,” Lombardi said.

“If not, then further investigation is necessary.”

© 2017 Global News, a division of Corus Entertainment Inc.

 

Bullboard Posts